Skip to content

Effect of ANCIL on diabetic foot wounds

Effect of ANSIL(Silver nanoparticles) solution on Diabetic foot wounds: A double-blind clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190701044062N9
Enrollment
80
Registered
2021-10-11
Start date
2021-10-16
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic foot ulcers. Personal history of diabetic foot ulcer

Interventions

Intervention 1: Intervention group: 20 patients with diabetic foot ulcer receive50ppm of ANCIL solution twice a day for 28days and bandaged on the wound. ANCIL solution: ASEPE comp

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Diabetic patients taking insulin with diabetic wound Age range 18 to 80 years

Exclusion criteria

Exclusion criteria: Patients with infectious wounds Sensitivity to topical formulations Patients who need surgery for their wounds

Design outcomes

Primary

MeasureTime frame
The severity of a diabetic foot ulcer is measured using the Texas Scoring System. Timepoint: Before the intervention and 7, 14, 21, and 28 days after the intervention. Method of measurement: The severity of diabetic foot ulcers in patients receiving ANCIL and placebo solution before the intervention and on days 7, 14, 21, and 28 after the intervention is measured using the Texas scoring system. Texas scoring system for diabetic foot ulcers to 4 degrees (0 to 3 Grade 1 is classified according to wound depth, infection, and ischemia as Grade 0 before or after the wound has healed, Grade 1 of a superficial wound that has not involved a tendon, capsule, or bone. Grade 2: The wound has penetrated a tendon or capsule. Grade 3: The wound has penetrated the bone or joint. Stage A: clean wound, Stage B: non-infectious and non-ischemic, Stage C: ischemic and non-ischemic, Stage D: Infectious and ischemic wound.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShima Khademi

Tabriz University of Medical Sciences

Khademishima94@gmail.com+98 41 3662 8155

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026